SLU Research: PTSD Is a Modifiable Risk Factor for Type 2 Diabetes, Related Adverse Outcomes
ST. LOUIS — Patients with post-traumatic stress disorder (PTSD) and type 2 diabetes have worse glycemic control, increased risk of hospitalization, and poorer self-reported health compared with type 2 diabetes alone, according to a Saint Louis University study.
The study, published online Aug. 13 in JAMA Network Open, shows that treating PTSD is associated with better overall well-being and lower risk of some chronic health conditions, including type 2 diabetes.
Jeffrey Scherrer, Ph.D., professor of family and community medicine and professor of psychiatry and behavioral neuroscience at Saint Louis University School of Medicine. Scherrer is also co-director of research for SLU’s Advanced HEAlth Data Research Institute. SLU file photo.
“To our knowledge, this is the first evidence that PTSD is a modifiable risk factor, albeit a modest one, for some adverse diabetes outcomes such as microvascular complications,” said Jeffrey Scherrer, Ph.D., professor of family and community medicine and professor of psychiatry and behavioral neuroscience at Saint Louis University School of Medicine, the paper’s senior author.
Scherrer is also co-director of research for SLU’s Advanced HEAlth Data (AHEAD) Research Institute, a center that addresses public health issues to improve patient health outcomes through data-driven innovation.
"This is further evidence that we should not separate mental from physical health. Treating the whole patient with comorbid PTSD and diabetes should address both conditions to optimize outcomes. Screening for and treating PTSD as part of diabetes care may lead to better clinical outcomes for both conditions," he said.
In this retrospective study, Scherrer and his co-authors collected patient data from 2011 to 2022 from the Veterans Health Administration (VHA). The data sets were comprised of 10,002 VHA patients, ages 18 to 80, with comorbid PTSD and type 2 diabetes.
Scherrer and his co-authors observed that when patients’ PTSD improved to a level where they no longer met the criteria for PTSD, that improvement was associated with an 8% reduction in risk for microvascular complications compared to those who continued to meet the criteria associated with a PTSD diagnosis. Among those ages 18-49, but not among older patients, no longer meeting PTSD criteria was linked to a significantly lower risk of insulin initiation and all-cause mortality.
PTSD is a metabolic disease related to the body’s inflammatory response. Scherrer and his co-authors found that it is possible that physiological abnormalities in the hypothalamic-pituitary-adrenal axis, changes in metabolic hormones, poor diet and a lack of exercise could explain the connection between PTSD and prediabetes and type 2 diabetes.
Other authors include Joanne Salas, of the AHEAD Research Institute, Saint Louis University School of Medicine; Wenjin Wang, of the Department of Family and Community Medicine, Saint Louis University School of Medicine; Kenneth E. Freedland, Ph.D., of the Department of Psychiatry, Washington University School of Medicine; Patrick J. Lustman, Ph.D., of the Department of Psychiatry, Washington University School of Medicine; Paula P. Schnurr, Ph.D., of the National Center for PTSD, White River Junction, Vermont, and the Department of Psychiatry, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire; Beth E. Cohen, M.D., of the Department of Medicine, University of California San Francisco School of Medicine and San Francisco VA Medical Center, San Francisco, California; Allan S. Jaffe, M.D. of the Department of Cardiovascular Medicine and Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota; Matthew J. Friedman, MD, Ph.D., of the Department of Psychiatry, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire.
This study was supported by grant R01HL160553 from the National Heart, Lung, and Blood Institute.
Latest Newslink
- SLU Researchers Identify Sex-Based Differences in Immune Responses Against TumorsResearchers at Saint Louis University School of Medicine investigated differences in T-cell responses between male and female patients with lung cancer that may help direct future treatments. T-cell responses are part of the adaptive immune system, which is part of the body's "smart system" that monitors for threats and fights them with customized defenses.
- Department of Energy Awards Saint Louis University Nearly $1 Million to Create a Climate Resilience CenterSaint Louis University has received a $964,848 grant from the U.S. Department of Energy (DOE) to create a Climate Resilience Center at SLU. The project is one of 10 centers funded by the DOE in states nationwide.
- SLU’s Farzana Hoque Named a YWCA Metro St. Louis 2024 Leader of DistinctionNominees are put forth by their peers and selected by an independent panel based on their professional achievements and contributions to the community. Farzana Hoque, M.D., associate professor of internal medicine and acting internship co-director, will be honored at the 44th Annual YWCA Leader Lunch on Friday, Dec. 13.
- SLU’s Alec Pollard Receives International OCD Foundation Outstanding Career Achievement AwardAlec Pollard, Ph.D., professor emeritus of family and community medicine, recently received the International OCD Foundation (IOCDF)’s 2024 Outstanding Career Achievement Award. The IOCDF Awards recognize exceptional individuals and professionals for their dedicated efforts in advancing awareness, advocacy, and understanding of obsessive-compulsive disorder.
- SLU Pregnancy Loss Researcher Denise Côté-Arsenault Receives Fulbright Specialist Program AwardDenise Côté-Arsenault, Ph.D., the Hemak Endowed professor of maternal child nursing, has received a Fulbright Specialist Program award, the U.S. Department of State and the Fulbright Foreign Scholarship Board recently announced.
- Pioneering Breast Surgeon Gives $7.3 Million to Saint Louis University to Support Catholic Education, Underserved CommunitiesSaint Louis University announced a historic donation to the University’s School of Education from physician and alumna Virginia (Ginny) Herrmann, M.D. The $7.3 million gift will establish the Herrmann Center for Innovative Catholic Education, as well as support education programs at every educational level and underserved students throughout the St. Louis region.